Health

Happify to launch prescription app for depression under loosened FDA rules


Happify to launch prescription app for depression under loosened FDA rules

Leveraging Food and Drug Administration regulations loosened during the pandemic, Happify Health, which is best known for its consumer wellness app, will launch new prescription-only software to treat depression.

Happify, founded in 2012, recently announced it had raised $73 million to bolster its efforts in digital therapeutics, a space that is rapidly growing as well-funded companies make the case to regulators, insurers, and clinicians that software can be used to treat disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED




Source link

Back to top button